Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

No Thumbnail Available
Authors
Monk, Bradley J.
Sill, Michael W.
Hanjani, Parviz
Edwards, Robert
Rotmensch, Jacob
De Geest, Koen
Bonebrake, Albert J.
Walker, Joan L.
Issue Date
2011
Type
Journal Article
Language
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Description
Citation
Monk, Bradley J.; Sill, Michael W.; Hanjani, Parviz; Edwards, Robert; Rotmensch, Jacob; De Geest, Koen; Bonebrake, Albert J.; Walker, Joan L. Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group. Gynecologic oncology. 2011, . 120(3):459-463.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
0090-8258
1095-6859
EISSN